Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma

published_or_final_versio

ICE/BEAM chemotherapy & peripheral blood stem cell (pbsc) rescue for relapse after bone marrow transplantation (BMT)

published_or_final_versio

Intensive chemotherapy with peripheral blood stem cell (PBSC) support in the treatment of leukemia relapse after allogeneic bone marrow transplantation: clinical results and chimerism findings

published_or_final_versio

Intensive chemotherapy with peripheral blood stem cell (PBSC) support in the treatment of leukemia relapse after allogeneic bone marrow transplantation: clinical results and chimerism findings

published_or_final_versio

Sustained and repeated response of relapsed acute promyelocytic leukemia (APL) to arsenic therapy

published_or_final_versio

Donor Lymphocyte Infusion (DLI) for leukemia relapse: a revisit

published_or_final_versio

The adjunctive use of Chinese medicine in non-surgical periodontal therapy

published_or_final_versio

Development of a Bonner Sphere neutron spectrometer from a commercial neutron dosimeter

Bonner Spheres have been used widely for the measurement of neutron spectra with neutron energies ranged from thermal up to at least 20 MeV . A Bonner Sphere neutron spectrometer (BSS) was developed by extending a Berthold LB 6411 neutron-dose-rate meter. The BSS consists of a 3He thermal-neutron detector with integrated electronics, a set of eight polyethylene spherical shells and two optional lead shells of various sizes. The response matrix of the BSS was calculated with GEANT4 Monte Carlo simulation. The BSS had a calibration uncertainty of ± 8.6% and a detector background rate of (1.57 ± 0.04) × 10−3 s−1. A spectral unfolding code NSUGA was developed. The NSUGA code utilizes genetic algorithms and has been shown to perform well in the absence of a priori information.postprin

Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas

published_or_final_versio

Anti-inflammatory treatment increased exhaled nitric oxide production on patients with active bronchiectasis

published_or_final_versio